Evidence map›Paper›PMID 36230768›Full record

ArticleCancers2022

Regulation of TGF-

Jin Seok Hwang, Trang Huyen Lai, Mahmoud Ahmed, Trang Minh Pham, Omar Elashkar, Entaz Bahar, Deok Ryong Kim

Abstract read
In one paragraph

Article in Cancers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jin Seok HwangDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-2051-504X
Trang Huyen LaiDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0003-4619-6558
Mahmoud AhmedDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-4377-6541
Trang Minh PhamDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0003-1862-464X
Omar ElashkarDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-5505-778X
Entaz BaharDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-4403-7978
Deok Ryong KimDepartment of Convergence Medical Science and Biochemistry, Institute of Health Sciences, Gyeongsang National University College of Medicine, Jinju 52727, Korea.ORCID 0000-0002-3288-8257

Funding

Ministry of Science ICT and Future Planning 2020R1A2C2011416
6 · The paper itself

Abstract

Metastasis is associated with poor prognosis and is the major cause of death in cancer patients. The epithelial to mesenchymal transition (EMT) is essential for cancer cells to acquire a highly migratory phenotype. Metabolic reprogramming is required to meet the energy demands during this process. Recent studies have indicated that autophagy is involved in EMT, during which cancer cells depend on autophagy activation for survival. However, accumulating evidence indicates that autophagy's involvement in cancer is context-dependent, acting as either promoter or inhibitor. In this study, we investigated the role of autophagy in supplying energy to support EMT. We induced EMT in Non-small cell lung cancer A549 cells using TGF-β1 with and without autophagy inhibition. Suppression of autophagy activity by knocking down of

Indexed as

A549 cellsautophagyEMTenergy metabolismTGF-β1

Identifiers

PMID36230768
PMCPMC9563415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.